Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06387134
Status:
RECRUITING
Last Update Posted:
2024-04-26
First Post:
2024-04-17
Brief Title:
Lifei Xiaoji Wan Treatments of Early-stage NSCLC and Its Impact on the Tumor Microenvironment
Sponsor:
Henan University of Traditional Chinese Medicine
Organization:
Henan University of Traditional Chinese Medicine
Study Overview
Official Title:
Study on the Therapeutic Effect of Lifei Xiaoji Wan on Lung Adenocarcinoma in the Early Stage of Ground Glass Nodule Ia Stage and Its Effect on Tumor Microenvironment
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluated the relationship between the clinical efficacy histopathological changes and tumor microenvironment of the pharmacopharmacologic Lifei Xiaoji Wan in the treatment of early stage lung adenocarcinoma and improved high-level clinical evidence and action targets for the prevention and treatment of early stage lung cancer by traditional Chinese medicine
Detailed Description:
Lung cancer is a malignant tumor with the highest morbidity and mortality The microenvironment of tumor plays an important role in its occurrence and developmentTraditional Chinese medicine has great advantages in the prevention and treatment of ground glass pulmonary nodules but there is a lack of high-level clinical evaluation evidence and precise mechanism of actionLifei Xiaoji Wan is a prescription based on the theory of gas accumulation causing cancer It has good curative effect in treating non-small cell lung cancer
In this study a single-center randomized controlled study was used to set up a treatment group and a control group to observe and evaluate the clinical efficacy of Lifeixiaoji pills on patients with early stage lung adenocarcinoma of ground glass nodules Flow cytometry PCR array and multiple fluorescence immunofluorescence were used to detect the tumor microenvironment in lung cancer tissues To investigate the effect of Lifeixiaoji pill on tumor microenvironment and its mechanism of action on early lung adenocarcinoma
In this study a single-center randomized controlled study was used to set up a treatment group and a control group to observe and evaluate the clinical efficacy of Lifeixiaoji pills on patients with early stage lung adenocarcinoma of ground glass nodules Flow cytometry PCR array and multiple fluorescence immunofluorescence were used to detect the tumor microenvironment in lung cancer tissues To investigate the effect of Lifeixiaoji pill on tumor microenvironment and its mechanism of action on early lung adenocarcinoma
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None